TY - JOUR
T1 - α-melanotropin
T2 - The minimal active sequence in the lizard skin bioassay
AU - Castrucci, A. M.L.
AU - Hadley, M. E.
AU - Sawyer, T. K.
AU - Wilkes, B. C.
AU - Al-Obeidi, F.
AU - Staples, D. J.
AU - de Vaux, A. E.
AU - Dym, O.
AU - Hintz, M. F.
AU - Riehm, J. P.
AU - Rao, K. R.
AU - Hruby, V. J.
N1 - Funding Information:
This research was supported by grants from the U.S. Public Health Service (AM-17420, V.J.H.; AR-36021, M.E.H.) and the National Science Foundation (DCB 8615706, M.E.H.) and the Conselho National de Desenvolvimento Cientitico e Tecnologico 407196/87, Brazil (A.M.C.).
PY - 1989/1
Y1 - 1989/1
N2 - α-Melanotropin (α-melanocyte-stimulating hormone, α-MSH) is a tridecapeptide, Ac-Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH2. The minimal sequence of α-MSH required for agonism in the lizard (Anolis carolinensis) skin bioassay was determined to be Ac-His-Phe-Arg-Trp-NH2 (Ac-α-MSH6-9-NH2). Smaller fragments of this sequence (Ac-α-MSH6-8-NH2, Ac-α-MSH6-7-NH2, Ac-α-MSH7-9-NH2, and Ac-α-MSH7-8-NH2) were devoid of melanotropic activity. The tetrapeptide, Ac-α-MSH7-10-NH2, was also inactive, thus again demonstrating the importance of His at position 6 for minimal activity. The important potentiating amino acids were found to be Met-4, Lys-11, and Pro-12, since Ac-α-MSH4-10-NH2 was about 100 times more potent than Ac-α-MSH5-10-NH2, and Ac-[Nle4]-α-MSH4-11-NH2 was about 40 times more potent than Ac-α-MSH4-10-NH2 or Ac-[Nle4]-α-MSH4-10-NH2. Ac-α-MSH4-12-NH2 and Ac-[Nle4]-α-MSH4-12-NH2 were equipotent and about six times more potent than α-MSH. Since [Nle4]-α-MSH and Ac-[Nle4]-α-MSH4-13-NH2 were both equipotent but about sixfold less active than Ac-[Nle4]-α-MSH4-12-NH2, it is clear that valine at position 13 does not contribute to the potency of α-MSH, except possibly in a negative way. The minimal message sequence for equipotency to α-MSH appears to be Ac-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-NH2, since the analog, Ac-[Nle4]-α-MSH4-11-NH2, was as active as the native hormone. Ser-1, Tyr-2, Ser-3, Glu-5, and Val-13 are not important for melanotropic potency since Ac-α-MSH4-12-NH2 was more potent than α-MSH, and Ac-α-MSH5-10-NH2 and Ac-α-MSH6-10-NH2 were equipotent, being about 4,000 times less active than α-MSH.
AB - α-Melanotropin (α-melanocyte-stimulating hormone, α-MSH) is a tridecapeptide, Ac-Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH2. The minimal sequence of α-MSH required for agonism in the lizard (Anolis carolinensis) skin bioassay was determined to be Ac-His-Phe-Arg-Trp-NH2 (Ac-α-MSH6-9-NH2). Smaller fragments of this sequence (Ac-α-MSH6-8-NH2, Ac-α-MSH6-7-NH2, Ac-α-MSH7-9-NH2, and Ac-α-MSH7-8-NH2) were devoid of melanotropic activity. The tetrapeptide, Ac-α-MSH7-10-NH2, was also inactive, thus again demonstrating the importance of His at position 6 for minimal activity. The important potentiating amino acids were found to be Met-4, Lys-11, and Pro-12, since Ac-α-MSH4-10-NH2 was about 100 times more potent than Ac-α-MSH5-10-NH2, and Ac-[Nle4]-α-MSH4-11-NH2 was about 40 times more potent than Ac-α-MSH4-10-NH2 or Ac-[Nle4]-α-MSH4-10-NH2. Ac-α-MSH4-12-NH2 and Ac-[Nle4]-α-MSH4-12-NH2 were equipotent and about six times more potent than α-MSH. Since [Nle4]-α-MSH and Ac-[Nle4]-α-MSH4-13-NH2 were both equipotent but about sixfold less active than Ac-[Nle4]-α-MSH4-12-NH2, it is clear that valine at position 13 does not contribute to the potency of α-MSH, except possibly in a negative way. The minimal message sequence for equipotency to α-MSH appears to be Ac-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-NH2, since the analog, Ac-[Nle4]-α-MSH4-11-NH2, was as active as the native hormone. Ser-1, Tyr-2, Ser-3, Glu-5, and Val-13 are not important for melanotropic potency since Ac-α-MSH4-12-NH2 was more potent than α-MSH, and Ac-α-MSH5-10-NH2 and Ac-α-MSH6-10-NH2 were equipotent, being about 4,000 times less active than α-MSH.
UR - http://www.scopus.com/inward/record.url?scp=0024562277&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0024562277&partnerID=8YFLogxK
U2 - 10.1016/0016-6480(89)90066-X
DO - 10.1016/0016-6480(89)90066-X
M3 - Article
C2 - 2537778
AN - SCOPUS:0024562277
VL - 73
SP - 157
EP - 163
JO - General and Comparative Endocrinology
JF - General and Comparative Endocrinology
SN - 0016-6480
IS - 1
ER -